22
Participants
Start Date
October 31, 2015
Primary Completion Date
April 30, 2016
Study Completion Date
April 30, 2016
DSM265 400mg
DSM265 400mg, single oral administration in a fed state
Placebo to DSM265 400 mg
Placebo to DSM265 400mg, single oral administration in a fed state
Plasmodium falciparum sporozoite challenge
IV Plasmodium falciparum sporozoites (3200) by direct venous inoculation
Malarone
250 mg atovaquone, 100 mg proguanil hydrochloride
Universitätsklinikum Tübingen, Institut für Tropenmedizin, Tübingen
Institute of Tropical Medicine, University of Tuebingen
OTHER
Medicines for Malaria Venture
OTHER